Histamine releasing peptide (HRP) has proinflammatory effects and is present at sites of inflammation

Biochemical Pharmacology

Volumn 66, Issue 2, 2003, Pages 331-342

  Cochrane, David E ^a   Carraway, Robert E ^b   Miller, Lisa A ^a   Feldberg, Ross S ^a   Bernheim, Harry ^a  

^a TUFTS UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Albumin derived peptide; Chymase; Inflammation; Mast cell; Protease generated peptide

Indexed keywords

1,10 PHENANTHROLINE; CROMOGLYCATE DISODIUM; DIPHENHYDRAMINE; ENZYME INHIBITOR; HISTAMINE RELEASING PEPTIDE; PEPTIDE DERIVATIVE; PROTEINASE; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CHEMOTAXIS; CONTROLLED STUDY; EDEMA; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE; MACROPHAGE; MALE; MAST CELL; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT;

EID: 0037756821     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00251-X     Document Type: Article

References (61)

1. Caughey G.H., Raymond W.W., Wolters P.J. Angiotensin II generation by mast cell α and β-chymases. Biochem. Biophys. Acta. 1480:2000;245-257.
2. Halim N.S. Small molecules in large proteins. Scientist. 14:2000;20-21.
3. Kaplan A.P., Joseph K., Silverberg M. Pathways for bradykinin formation and inflammatory disease. J. Allergy Clin. Immunol. 109:2002;195-209.
4. Vallotton M.B. The renin-angiotensin system. Trends Pharmacol. 8:1987;69-74.
5. Cornelius L.A., Nehring L.C., Harding E., Bolanowski M., Welgus H.G., Kobayashi D.K., Pierce R.A., Shapiro S.D. Matrix metalloproteinases generate angiostatin: effects on neovascularization. J. Immunol. 161:1998;6845-6852.
6. Sasaki T., Fukai N., Mann K., Gohring W., Olsen B., Timpl R. Structure and function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. EMBO J. 17:1998;4249-4256.
7. Movat HZ. The acute inflammatory reaction. In: Movat HZ, editor. Inflammation immunity and hypersensitivity. 2nd ed. New York: Harper & Row; 1979. p. 1-162.
8. Nilsson G, Costa J, Metcalfe DD. Mast cells and basophils. In: Gallin JI, Snyderman R, editors. Inflammation: basic principles and clinical correlates. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 1999. p. 97-118.
9. Carraway R.E., Cochrane D.E., Boucher W., Mitra S.P. Structures of histamine-releasing peptides formed by the action of acid proteases on mammalian albumin(s). J. Immunol. 143:1989;1680-1684.
10. Cochrane D.E., Carraway R.E., Feldberg R.S., Boucher W., Gelfand J.M. Stimulated rat mast cells generate histamine-releasing peptides from albumin. Peptides. 14:1992;117-123.
11. Cochrane D.E., Boucher W., Carraway R.E. Formation of histamine releasing activity from albumin by medium conditioned by endotoxin-stimulated rat peritoneal macrophages. Agents Actions. 35:1992;19-28.
12. Cochrane D.E., Boucher W., Carraway R.E. Generation of histamine-releasing activity from serum albumin by medium derived from stimulated neutrophils of rat. Br. J. Pharmacol. 97:1989;524-532.
13. Cochrane D.E., Carraway R.E., Feldberg R.S. HRP an albumin derived protease generated pro-inflammatory peptide. Inflamm. Res. 50:2001;S195.
14. Cochrane D.E., Carraway R.E., Boucher W., Feldberg R.S. Rapid degradation of neurotensin by stimulated rat mast cells. Peptides. 121:1991;87-94.
15. Cochrane D.E., Boucher W., Bibb P. Neurotensin stimulates histamine release in in vivo skin blisters in rats: an effect inhibited by cromolyn or somatostatin. Int. Arch. Allergy Appl. Immunol. 80:1986;225-230.
16. Carraway R.E., Cochrane D.E., Lansman J.B., Leeman S.E., Paterson B.M., Welch H.J. Neurotensin stimulates exocytotic histamine secretion from rat mast cells and elevates plasma histamine levels. J. Physiol. 323:1982;403-414.
17. Miller L.A., Cochrane D.E., Carraway R.E., Feldberg R.S. Blockade of mast cell histamine secretion in response to neurotensin by Sr 48692 a nonpeptide antagonist of the neurotensin brain receptor. Br. J. Pharmacol. 114:1995;1466-1470.
18. Wershil B.K., Murakami T., Galli S.J. Mast cell-dependent amplification of an immunologically nonspecific inflammatory response mast cells are required for the full expression of cutaneous acute inflammation induced by phorbol 12-myristate 13-acetate. J. Immunol. 140:1988;2356-2360.
19. Wershil B.K., Wang Z.S., Gordon J.P., Galli S.J. Recruitment of neutrophils during IgE-dependent cutaneous late phase responses in the mouse is mast cell dependent: partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J. Clin. Invest. 87:1991;446-453.
20. Cramer E.B., Gallin J.I. Localization of submembranous cations to the leading edge of human neutrophils during chemotaxis. J. Cell Biol. 82:1979;369-379.
21. Gabay C. Cytokine inhibitors in the treatment of rheumatoid arthritis. Exp. Opin. Biol. Ther. 2:2002;135-149.
22. Li Y., Loike J.D., Ember J.A., Cleary P.P., Lu E., Budho S., Cao L., Silverstein S.C. The bacterial peptide N-formyl-met-leu-phe inhibits killing of Staphylococcus epidermis by human neutrophils in fibron gels. J. Immunol. 168:2002;816-824.
23. Wilkinson PC. Micropore filter methods for leukocyte chemotaxis. In: Sabato GD, editor. Methods in enzymology, vol. 162. Part L. New York: Academic Press; 1988. p. 38-50.
24. Cochrane D.E., Carraway R.E., Boucher W. Generation of xenopsin-related peptides from tissue precursors by media conditioned by endotoxin-stimulated rat peritoneal macrophages. Inflammation. 15:1991;381-390.
25. Kjeldsen L., Sengelov H., Borregaard N. Subcellular fractionation of human neutrophils on Percoll density gradients. J. Immunol. Methods. 232:1999;131-143.
26. Vogel S.N., Rosenstreich D.L. Defective Fc receptor-mediated phagocytosis in C3H/HeJ macrophages. I. Correction by lymphokine-induced stimulation. J. Immunol. 123:1979;2842-2850.
27. Joyce T.J., Yood R.A., Carraway R.E. Quantitation of substance-P and its metabolites in plasma and synovial fluid from patients with arthritis. J. Clin. Endocrinol. Metab. 77:1993;632-637.
28. Graninger W.B., Smolen J.S. One-year inhibition of tumor necrosis factor-alpha: a major success or a larger puzzle? Curr. Opin. Rheumatol. 13:2001;209-213.
29. McNeil H.P. The mast cell and inflammation. Aust. N.Z. J. Med. 26:1996;216-225.
30. Gurish M.F., Austen K.F. The diverse roles of mast cells. J. Exp. Med. 194:2002;F1-F5.
31. Ferry X., Brehin S., Kamel R., Landry Y. G-protein dependent activation of mast cells by peptides and basic secretagogues. Peptides. 23:2002;1507-1515.
32. Cochrane D.E., Harbert C., Luu L., Feldberg R.S. Neurotensin (NT) induced homologous and heterologous desensitization of mast cell secretion. FASEB J. 13:1999;A847.
33. Ferguson S.S.G. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol. Rev. 53:2001;1-24.
34. Cochrane D.E., Carraway R.E., Hartunian M., Sawyer R., Barrocas A. Immunological detection of a mast cell neurotensin (NT) receptor. Mol. Biol. Cell. 6:1995;1022.
35. Feldberg R.S., Cochrane D.E., Carraway R.E., Brown E., Sawyer R., Hartunian M., Wentworth D. Evidence for a neurotensin receptor in rat serosal mast cells. Inflamm. Res. 47:1998;245-250.
36. White M.V., Kaplan A.P., Haak-Frendsoho M., Kaliner M. Neutrophils and mast cells comparison of neutrophil derived histamine releasing activity with other histamine releasing factors. J. Immunol. 141:1988;3537-3543.
37. Woodward D.F., Owen D.A.A., Pipkin M.A., Ledgard S.E. Histamine involvement in the local and systemic microvasculature effects produce by intradermal substance P. Agents Actions. 17:1985;126-130.
38. Yano H., Wershil B.K., Arizono N., Galli S.J. Substance P-induced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell dependent. J. Clin. Invest. 84:1989;1276-1286.
39. Theoharides T.C., Spanos C.P., Pang X., Letourneau R., Webster E., Chrouso's G. Corticotropin-releasing hormone induces mast cell degranulation and increased vascular permeability a possible explanation for its proinflammatory effects. Endocrinology. 139:1998;403-413.
40. Uhing RJ, Snyderman R, Chemoattractant stimulus-response coupling. In: Gallin JI, Snyderman R, editors. Inflammation: basic principles and clinical correlates. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 1999. p. 607-26.
41. Greenberg S. Biology of phagocytosis. In: Gallin JI, Snyderman R, editors. Inflammation: basic principles and clinical correlates. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 1999. p. 681-701.
42. Haribabu B., Richardson R.M., Verghese M.W., Barr A.J., Zhelev D.V., Snyderman R. Function and regulation of chemoattractant receptors. Immunol. Res. 22:2000;271-279.
43. Aronin N., Carraway R.E., Ferris C.F., Hammer R.A., Leeman S.E. The stability and metabolism of intravenously administered neurotensin in the rat. Peptides. 3:1982;637-642.
44. He S., Walls A.F. The induction of a prolonged increase in microvascular permeability by human mast cell chymase. Eur. J. Pharmacol. 352:1998;91-98.
45. He S., Walls A.F. Human mast cell chymase induces the accumulation of neutrophils eosinophils and other inflammatory cells in vivo. Br. J. Pharmacol. 125:1998;1491-1500.
46. Singh L., Pang X., Alexakos N., Letourneau R., Theoharides T.C. Acute immobilization stress triggers skin mast cell degranulation via corticotrophin-releasing hormone neurotensin and substance P: a link to neurogenic skin diseases. Brain Behav. Immun. 13:1999;225-239.
47. Borregaard N., Kjeldsen L., Rygaad K., Bastholm L., Nielsen M.H., Sengelov H., Berron O.W., Johnsen A.H. Stimulus-dependent secretion of plasma proteins from human neutrophils. J. Clin. Invest. 90:1992;86-96.
48. Marcus AJ. Platelets: their role in hemostasis thrombosis and inflammation. In: Gallin JI, Snyderman R, editors. Inflammation: basic principles and clinical correlates. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 1999. p. 77-9.
49. Carraway R.E., Mitra S.P., Muraki K. Xenopsin-related peptide(s) are formed from Xenopsin precursor by leukocyte protease(s) and cathepsin D. Peptides. 12:1991;107-112.
50. Gao G.C., Wei E.T. Xenopsin neurotensin neurotensin(8-13) and N-acetyl-neurotensin(8-13) inhibit vascular leakage in rats after tissue injury. J. Pharmacol. Exp. Ther. 265:1993;619-625.
51. Carraway R.E., Mitra S.P., Cochrane D.E. Pro-xenopsin(s) in vesicles of mammalian brain, liver, stomach, and intestine is apparently released into blood and cerebral spinal fluid. Regul. Pept. 95:2000;115-124.
52. Kavanaugh AF, Lipsky PE. Rheumatoid arthritis. In: Gallin JI, Snyderman R, editors. Inflammation: basic principles and clinical correlates. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 1999. p. 1017-38.
53. Woolley D.E., Tetlow L.C. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Arthritis Res. 2:2000;65-74.
54. Peltonen L., Puranen J., Lehinen K., Korhonen L.K. Proteolytic enzymes in joint destruction. Scand. J. Rheumatol. 10:1981;107-114.
55. Scott D., Coleman P.J., Mason R.M., Levick J.R. Interaction of intraarticular hyaluronan and albumin in the attenuation of fluid drainage from joints. Arthritis Rheum. 43:2000;1175-1182.
56. Lee D.M., Friend D.S., Gurish M.F., Benoist C., Mathis D., Brenner M.B. Mast cells: a cellular limb between autoantibodies and inflammatory arthritis. Science. 297:2002;1689-1692.
57. Cortese T.A. Jr., Sams W.M., Sulzberger M.B. Studies on blisters produced by friction II blister fluid. J. Invest. Dermatol. 50:1968;47-53.
58. Knapik J.J., Reynolds K.L., Duplantis K.L., Jones B. Friction blisters: pathophysiology prevention and treatment. Sports Med. 20:1995;136-147.
59. Worm A.M. Exchange of macromolecules between plasma and skin interstitium in extensive skin disease. J. Invest. Dermatol. 76:1981;486-492.
60. Staberg B., Groth S., Rissing N. Passage of albumin from plasma to suction skin blisters. Clin. Physiol. 3:1983;375-380.
61. Katayama I., Doi T., Nishioka K. High histamine levels in blister fluid of Bullous Pemphigoid. Arch. Dermatol. Res. 276:1984;126-127.